Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
GRNY vs XLV: how they differ
GRNY and XLV hold 2% of their weight in the same names, and XLV returned more over the year.
Fundstrat Granny Shots US Large Cap ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, GRNY and XLV hold 2% of their money in the same securities at the same weight.
| Holding | GRNY | XLV |
|---|---|---|
| Amgen Inc | 2.15% | 3.41% |
| Only in GRNY | Only in XLV |
|---|---|
| Advanced Micro Devices Inc 4.17% | Eli Lilly & Co 16.56% |
| Quanta Services Inc 3.20% | Johnson & Johnson 10.67% |
| GE Vernova Inc 3.05% | AbbVie Inc 7.76% |
| Amazon.com Inc 3.02% | UnitedHealth Group Inc 6.59% |
| Strategy Inc 3.01% | Merck & Co Inc 5.54% |
| Alphabet Inc 2.96% | Thermo Fisher Scientific Inc 3.25% |
| Broadcom Inc 2.94% | Abbott Laboratories 2.76% |
| Arista Networks Inc 2.88% | Gilead Sciences Inc 2.74% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| GRNY Fundstrat Granny Shots US Large Cap ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Fundstrat | State Street |
| What it is | Fundstrat Granny Shots US Large Cap | Health care |
| Total return, 1 year | +13.8% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −3.7 pts | +2.9 pts |
| Expense ratio | 0.75% | 0.08% |
| Already in the S&P 500 | 97.0% | 100.0% |
| Holdings | 40 | 59 |
GRNY in plain words
GRNY is an index equity fund tracking the Fundstrat Granny Shots US Large Cap. Over the year to Sep 11, 2026 it returned +13.8% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.75% a year. By its holdings filed for Apr 30, 2026, 97% of the fund by weight is stocks the S&P 500 also holds, across 40 positions, with the top ten at 30.8%.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, GRNY or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, GRNY returned +13.8% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, GRNY or XLV?
- GRNY charges 0.75% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do GRNY and XLV overlap with the S&P 500?
- By their latest filed holdings, 97% of GRNY and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 2% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, GRNY against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/GRNY-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources